Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BLIS TechnologiesNZSE:BLT +9.09% 3-1 Month Momentum % is 26.67% as of Sep. 21, 2026. The stock has 8 warning signs investors should review. Among 1,382 Biotechnology companies, BLIS Technologies ranks better than 70.77% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-21), BLIS Technologies's 3-1 Month Momentum % is 26.67%.
The industry rank for BLIS Technologies's 3-1 Month Momentum % or its related term are showing as below:
NZSE:BLT's 3-1 Month Momentum % is ranked better than 70.77% of 1382
companies
in the Biotechnology industry
Industry Median: 0.36
vs NZSE:BLT: 26.67
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
BLIS Technologies 3-1 Month Momentum % Related Terms
NZSE:BLT vs VRTX, REGN, MRNA: 3-1 Month Momentum % Comparison
For the Biotechnology subindustry, BLIS Technologies's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BLIS Technologies 3-1 Month Momentum % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BLIS Technologies's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where BLIS Technologies's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BLIS Technologies (NZSE:BLT) has a 3-1 Month Momentum % of 26.67% as of Sep. 21, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on BLIS Technologies and its competitors. According to the industry distribution chart, BLIS Technologies ranks #404 out of 1382 companies in the Biotechnology industry, placing it in the top 29.2%.
Is BLIS Technologies' 3-1 Month Momentum % too high?
BLIS Technologies' current 3-1 Month Momentum % is 26.67%. The Biotechnology industry median 3-1 Month Momentum % is 0.36. BLIS Technologies' value of 26.67% is 7308.3% above this industry median. Based on the distribution chart, BLIS Technologies ranks #404 out of 1382 companies in the Biotechnology industry, which is above the industry midpoint.
How does BLIS Technologies' 3-1 Month Momentum % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BLIS Technologies ranks #404 out of 1382 companies for 3-1 Month Momentum %. This puts BLIS Technologies in the upper half of its industry. The industry median 3-1 Month Momentum % is 0.36. BLIS Technologies' value of 26.67% is 7308.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Biotechnology company?
The median 3-1 Month Momentum % among Biotechnology companies is 0.36, based on 1,382 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BLIS Technologies's current 3-1 Month Momentum % of 26.67% is 7308.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on BLIS Technologies and its competitors. For the Biotechnology industry, the median 3-1 Month Momentum % is 0.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BLIS Technologies's current 3-1 Month Momentum % is 26.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BLIS Technologies stock overvalued right now?
Based on GuruFocus' analysis, BLIS Technologies (NZSE:BLT) is currently considered Modestly Overvalued. The stock's GF Value™ is NZ$0.02, compared to a current price of NZ$0.02 — trading 20% above its estimated fair value. The current 3-1 Month Momentum % is 26.67% and 7308.3% above the Biotechnology industry median of 0.36. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For BLIS Technologies (NZSE:BLT), the current 3-1 Month Momentum % is 26.67% as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18, which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from North America. The company also generates a small portion of revenue from Non-core business, which includes grants and interest revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:BLT has been successfully added to your 
